These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 16928222

  • 1. Combinations containing amoxicillin-clavulanate and tetracycline are inappropriate for Helicobacter pylori eradication despite high in vitro susceptibility.
    Cheon JH, Kim SG, Kim JM, Kim N, Lee DH, Kim JS, Jung HC, Song IS.
    J Gastroenterol Hepatol; 2006 Oct; 21(10):1590-5. PubMed ID: 16928222
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of moxifloxacin-based triple therapy as second-line treatment for Helicobacter pylori infection.
    Cheon JH, Kim N, Lee DH, Kim JM, Kim JS, Jung HC, Song IS.
    Helicobacter; 2006 Feb; 11(1):46-51. PubMed ID: 16423089
    [Abstract] [Full Text] [Related]

  • 3. Second-line treatment for Helicobacter pylori infection: 10-day moxifloxacin-based triple therapy versus 2-week quadruple therapy.
    Kang JM, Kim N, Lee DH, Park YS, Kim YR, Kim JS, Jung HC, Song IS.
    Helicobacter; 2007 Dec; 12(6):623-8. PubMed ID: 18001404
    [Abstract] [Full Text] [Related]

  • 4. Bismuth-containing quadruple therapy as second-line treatment for Helicobacter pylori infection: effect of treatment duration and antibiotic resistance on the eradication rate in Korea.
    Lee BH, Kim N, Hwang TJ, Lee SH, Park YS, Hwang JH, Kim JW, Jeong SH, Lee DH, Jung HC, Song IS.
    Helicobacter; 2010 Feb; 15(1):38-45. PubMed ID: 20302588
    [Abstract] [Full Text] [Related]

  • 5. Ranitidine bismuth citrate-based triple therapies as a second-line therapy for Helicobacter pylori in Turkish patients.
    Köksal AS, Parlak E, Filik L, Yolcu OF, Odemiş B, Ulker A, Saşmaz N, Ozden A, Sahin B.
    J Gastroenterol Hepatol; 2005 Apr; 20(4):637-42. PubMed ID: 15836716
    [Abstract] [Full Text] [Related]

  • 6. Randomized study of two "rescue" therapies for Helicobacter pylori-infected patients after failure of standard triple therapies.
    Perri F, Festa V, Clemente R, Villani MR, Quitadamo M, Caruso N, Bergoli ML, Andriulli A.
    Am J Gastroenterol; 2001 Jan; 96(1):58-62. PubMed ID: 11197288
    [Abstract] [Full Text] [Related]

  • 7. A pilot study evaluating sequential administration of a PPI-amoxicillin followed by a PPI-metronidazole-tetracycline in Turkey.
    Sezgin O, Altintaş E, Nayir E, Uçbilek E.
    Helicobacter; 2007 Dec; 12(6):629-32. PubMed ID: 18001405
    [Abstract] [Full Text] [Related]

  • 8. The efficacy of bismuth containing quadruple therapy as a first-line treatment option for Helicobacter pylori.
    Uygun A, Kadayifci A, Safali M, Ilgan S, Bagci S.
    J Dig Dis; 2007 Nov; 8(4):211-5. PubMed ID: 17970879
    [Abstract] [Full Text] [Related]

  • 9. The efficacy of moxifloxacin-containing triple therapy after standard triple, sequential, or concomitant therapy failure for Helicobacter pylori eradication in Korea.
    Chung KH, Lee DH, Jin E, Cho Y, Seo JY, Kim N, Jeong SH, Kim JW, Hwang JH, Shin CM.
    Gut Liver; 2014 Nov; 8(6):605-11. PubMed ID: 25368747
    [Abstract] [Full Text] [Related]

  • 10. Comparison of sequential and standard triple-drug regimen for Helicobacter pylori eradication: a 14-day, open-label, randomized, prospective, parallel-arm study in adult patients with nonulcer dyspepsia.
    Uygun A, Kadayifci A, Yesilova Z, Safali M, Ilgan S, Karaeren N.
    Clin Ther; 2008 Mar; 30(3):528-34. PubMed ID: 18405790
    [Abstract] [Full Text] [Related]

  • 11. Eradication rates of helicobacter pylori infection with second-line treatment: non-ulcer dyspepsia compared to peptic ulcer disease.
    Chung SJ, Lee DH, Kim N, Jung SH, Kim JW, Hwang JH, Park YS, Lee KH, Jung HC, Song IS.
    Hepatogastroenterology; 2007 Jun; 54(76):1293-6. PubMed ID: 17629092
    [Abstract] [Full Text] [Related]

  • 12. Comparison of three different second-line quadruple therapies including bismuth subcitrate in Turkish patients with non-ulcer dyspepsia who failed to eradicate Helicobacter pylori with a 14-day standard first-line therapy.
    Uygun A, Ozel AM, Yildiz O, Aslan M, Yesilova Z, Erdil A, Bagci S, Gunhan O.
    J Gastroenterol Hepatol; 2008 Jan; 23(1):42-5. PubMed ID: 17559359
    [Abstract] [Full Text] [Related]

  • 13. A Randomized Controlled Trial Shows that both 14-Day Hybrid and Bismuth Quadruple Therapies Cure Most Patients with Helicobacter pylori Infection in Populations with Moderate Antibiotic Resistance.
    Tsay FW, Wu DC, Yu HC, Kao SS, Lin KH, Cheng JS, Wang HM, Chen WC, Sun WC, Tsai KW, Hsu PI.
    Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28807915
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Second-line Helicobacter pylori eradication: a randomized comparison of 1-week or 2-week bismuth-containing quadruple therapy.
    Chung JW, Lee JH, Jung HY, Yun SC, Oh TH, Choi KD, Song HJ, Lee GH, Kim JH.
    Helicobacter; 2011 Aug; 16(4):289-94. PubMed ID: 21762268
    [Abstract] [Full Text] [Related]

  • 17. Randomized comparison of two rescue therapies for Helicobacter pylori infection.
    Wu DC, Hsu PI, Chen A, Lai KH, Tsay FW, Wu CJ, Lo GH, Wu JY, Wu IC, Wang WM, Tseng HH.
    Eur J Clin Invest; 2006 Nov; 36(11):803-9. PubMed ID: 17032348
    [Abstract] [Full Text] [Related]

  • 18. [Comparative effect of lansoprazole/amoxicillin with omeprazole/amoxicillin for the eradication of Helicobacter pylori in patients with duodenal ulcer].
    Kayser S, Flury R, Zbinden R, Fried M, Wirth HP.
    Schweiz Med Wochenschr; 1997 Apr 26; 127(17):722-7. PubMed ID: 9221483
    [Abstract] [Full Text] [Related]

  • 19. Optimal treatment of Helicobacter pylori with ranitidine bismuth citrate (RBC): a randomized comparison between two 7-day triple therapies and a 14-day dual therapy.
    de Boer WA, Haeck PW, Otten MH, Mulder CJ.
    Am J Gastroenterol; 1998 Jul 26; 93(7):1101-7. PubMed ID: 9672338
    [Abstract] [Full Text] [Related]

  • 20. The efficacy of ranitidine bismuth citrate, amoxicillin and doxycycline or tetracycline regimens as a first line treatment for Helicobacter pylori eradication.
    Akyildiz M, Akay S, Musoglu A, Tuncyurek M, Aydin A.
    Eur J Intern Med; 2009 Jan 26; 20(1):53-7. PubMed ID: 19237093
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.